Author Archives: admin


Stem Cell Clinic > Articles by: admin

CorMedix to Participate in BIO Investor Forum Digital

By Global News Feed

BERKELEY HEIGHTS, N.J., Oct. 08, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that Matt David, M.D., Executive Vice President and Chief Financial Officer of CorMedix, will present a company overview and host one-on-one meetings during the 2020 BIO Investor Forum Digital, being held virtually October 13 – 15, 2020. The Company’s presentation will be available on demand for BIO Investor Forum attendees.

Original post:
CorMedix to Participate in BIO Investor Forum Digital

CohBar’s CEO to Participate on the Emerging Companies Panel at the Targeting Metabesity Conference

By Global News Feed

MENLO PARK, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will be a participant on the panel titled “Emerging Companies” at the Targeting Metabesity Conference, being held virtually on October 12-15, 2020. A live webcast of the presentation will be available for attendees who register at http://www.metabesity2020.com/register.html. Viewing is complimentary.

See the article here:
CohBar’s CEO to Participate on the Emerging Companies Panel at the Targeting Metabesity Conference

Aligos Therapeutics Presents Coronavirus Therapeutic Screening Assay Development at ISIRV-AVG Conference

By Global News Feed

SOUTH SAN FRANCISCO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Aligos), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that the company is presenting an e-poster at the virtual Therapeutics for COVID-19 meeting held by the International Society for Influenza and other Respiratory Virus Diseases-Antiviral Group (ISIRV-AVG), taking place October 6 – 8 from noon to 4 p.m. GMT.

Read more:
Aligos Therapeutics Presents Coronavirus Therapeutic Screening Assay Development at ISIRV-AVG Conference

FibroGenesis Named Top 20 Most Innovative Companies of 2020 and Lands at the #2 Spot on Global Smart Leaders Magazine List

By Global News Feed

HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is proud to announce Global Smart Leaders Magazine has named them the #2 Most Innovative Company of 2020. The detailed profile interview can be found here: https://globalsmartleaders.com/fibrogenesis-treatingcovid-19-and-other-chronic/

Visit link:
FibroGenesis Named Top 20 Most Innovative Companies of 2020 and Lands at the #2 Spot on Global Smart Leaders Magazine List

Stabilization measures taken

By Global News Feed

Orphazyme A/SCompany announcement                                                                                       No. 64/2020                                                                                                         Company Registration No. 32266355

More:
Stabilization measures taken

American Gene Technologies to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

By Global News Feed

ROCKVILLE, Md., Oct. 08, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) a cutting-edge cell and gene therapy company in Rockville, Maryland announced today that CEO Jeff Galvin will present at the annual Cell & Gene Meeting on the Mesa. The meeting will be held virtually October 12-16. Galvin’s presentation will highlight the company's technology, including AGT103-T, a therapeutic intended to cure HIV, which is scheduled to begin Phase 1 clinical trials this month.

Follow this link:
American Gene Technologies to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

→←